Health & bio

First Non-Psychiatric Dementia Agitation Treatment Approved

On April 30th, the FDA cleared the first non-psychiatric class medication for agitation associated with dementia, reducing elderly psychiatric care burden.

Primary sources · 1
← View the full 2026-05-03 (Sun) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →